Investor
The funding comes less than a year after the virtual mental health company closed a $125 million Series C funding round.
Duke-NUS Medical School's LIVE Ventures will bring together scientists and public and private sector entities to commercialize academic research concepts.
The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.
The digital health company will assist the healthcare system in identifying patients needing behavioral health services within its primary care population.
The funding will be used to secure FDA clearance for its benchtop blood-testing system for use in doctor's offices, clinics and pharmacies.
Thyme Care secures $60 million in Series B funding, and Neuspera Medical garners $23 million.
If investment patterns in the first half of 2024 persist, this year could exceed year-end totals seen in 2019 and 2023, according to Rock Health's H1 2024 digital health funding report.
Unseen Capital funds entrepreneurs of early-stage healthcare companies focused on addressing the needs of underserved communities.
The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.
The funding comes a year after the company announced an expanded relationship with OpenAI to develop a chatbot for healthcare providers built on GPT-4.